GoodRX | GDRX | Long at $5.00GoodRX NASDAQ:GDRX . Going long at $5.00.
Pros:
Revenue is growing and is expected to reach almost $1 billion by 2027
Debt-to-equity = 0.71x (low)
Monthly active users continue to increase (+7% during Q3 of 2024)
From a technical analysis perspective, the downward trend is starting to reverse, and the price has connected with my historical simple moving average (likely leading to a price increase)
Cons:
Not yet profitable
A lot of market competition
Insiders exercising of options outweighs awarding of options
No dividend
Targets:
$6.00
$7.00
$8.00
Substantially higher if partnerships emerge and profitability begins
